Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gynecologic Oncology
•
Palliation
•
Medical Oncology
•
Supportive Care
How would you manage a patient with FIGO stage IIIB endometrial carcinoma who developed significant back pain with Carboplatin/Paclitaxel cycle 1, which worsened during cycle 2?
Related Questions
How would you manage a rising CA-125 in a young patient on maintenance bevacizumab and olaparib x1 year for IIIC HR-deficient serous ovary cancer whose only finding on PETCT is a 1.5cm pelvic lymph node?
For a patient with IIIC1 (micromets), MSI-high, Grade 2 endometrial adenocarcinoma who has undergone full surgical staging, do you recommend adding immunotherapy to adjuvant chemotherapy + radiation?
Can defibrotide be given safely for VOD in patients with refractory thrombocytopenia to platelet transfusions?
How would you approach a patient who is unable to undergo the recommended ophthalmologic examinations during treatment with mirvetuximab soravtansine?
What is the optimal management of pain and loss of function due to pathologic compression fractures?
In SIADH due to malignancy, do you prefer to use free water restriction or salt tablets?
What are your top takeaways in Gyn Cancers from ESMO 2024?
In a patient with oligometastatic, recurrent Grade 2, ER+, MSI-high endometrioid adenocarcinoma who has a single, resectable metastasis to bone, what systemic therapy would you recommend and how would you time it in relation to possible surgery?
Would you offer adjuvant systemic therapy for recurrent fallopian tube leiomyosarcoma after resection of an isolated liver metastasis that presented within 1 year from primary surgery?
What are your top takeaways in Gyn Cancers from ASCO 2024?
